Cargando…
The Immunogenicity of Branded and Biosimilar Infliximab in Rheumatoid Arthritis According to Th9-Related Responses
Our objective was to evaluate the immunogenicity of branded and biosimilar infliximab by detecting changes in T-helper-9 (Th9) percentages induced by an in vitro stimulation test. Methods: Peripheral blood mononuclear cells collected from 55 consecutive rheumatoid arthritis (RA) outpatients (15 drug...
Autores principales: | Talotta, Rossella, Berzi, Angela, Doria, Andrea, Batticciotto, Alberto, Ditto, Maria Chiara, Atzeni, Fabiola, Sarzi-Puttini, Piercarlo, Trabattoni, Daria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5666809/ https://www.ncbi.nlm.nih.gov/pubmed/29023386 http://dx.doi.org/10.3390/ijms18102127 |
Ejemplares similares
-
Accelerated subcutaneous nodulosis in patients with rheumatoid arthritis treated with tocilizumab: a case series
por: Talotta, Rossella, et al.
Publicado: (2018) -
Reactivation of occult hepatitis B virus infection under treatment with abatacept: a case report
por: Talotta, Rossella, et al.
Publicado: (2016) -
Microbial Agents as Putative Inducers of B Cell Lymphoma in Sjögren's Syndrome through an Impaired Epigenetic Control: The State-of-The-Art
por: Talotta, Rossella, et al.
Publicado: (2019) -
The Microbiome in Connective Tissue Diseases and Vasculitides: An Updated Narrative Review
por: Talotta, Rossella, et al.
Publicado: (2017) -
Measurement of Serum Klotho in Systemic Sclerosis
por: Talotta, Rossella, et al.
Publicado: (2017)